Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Tumors × Maximum Tolerated Dose × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Multiple Myeloma 2 Triple Negative Breast Neoplasms 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Colorectal Neoplasms 1 Advanced Solid Tumors 1

Interventions

Injections 21 Carboplatin 16 Docetaxel 13 Paclitaxel 10 Bevacizumab 10 pembrolizumab 9 Fluorouracil 7 Cisplatin 7 durvalumab 6 Nivolumab 6 Leucovorin 6 trifluridine tipiracil drug combination 5 tislelizumab 5 linifanib 5 Pemetrexed 5 talazoparib 4 olaparib 4 Panobinostat 4 Oxaliplatin 4 Itraconazole 4 Irinotecan 4 Capecitabine 4 zimberelimab 3 toripalimab 3 sintilimab 3 fludarabine 3 depatuxizumab 3 atezolizumab 3 Sorafenib 3 ST 1481 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02994953 2024-09-20

COMBO

EMD Serono

Phase 1 Terminated

52 enrolled 34 charts

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡